Market Cap | 27.95M | P/E | - | EPS this Y | 29.80% | Ern Qtrly Grth | - |
Income | -10.44M | Forward P/E | -3.46 | EPS next Y | 21.20% | 50D Avg Chg | -10.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -19.00% |
Dividend | N/A | Price/Book | 3.94 | EPS next 5Y | - | 52W High Chg | -61.00% |
Recommedations | 2.00 | Quick Ratio | 4.82 | Shares Outstanding | 16.50M | 52W Low Chg | 135.00% |
Insider Own | 1.47% | ROA | -64.88% | Shares Float | 16.26M | Beta | 1.64 |
Inst Own | 8.01% | ROE | -134.46% | Shares Shorted/Prior | 271.01K/176.75K | Price | 2.35 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 4,056,372 | Target Price | 7.00 |
Oper. Margin | - | Earnings Date | Nov 12 | Volume | 88,307 | Change | -3.29% |
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
HC Wainwright & Co. | Buy | Jun 3, 24 |
HC Wainwright & Co. | Buy | Apr 16, 24 |
HC Wainwright & Co. | Buy | Oct 18, 23 |
HC Wainwright & Co. | Buy | Jun 26, 23 |
HC Wainwright & Co. | Buy | Jun 6, 23 |
HC Wainwright & Co. | Buy | May 9, 23 |
HC Wainwright & Co. | Buy | Aug 18, 20 |
HC Wainwright & Co. | Buy | Jan 13, 20 |
HC Wainwright & Co. | Buy | Dec 24, 19 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Bornstein Yoseph | Director Director | Oct 06 | Sell | 7.74 | 20,000 | 154,800 | 266,909 | 10/06/20 |